Biorestorative Therapies Inc. Revenue 2011–2025
Biorestorative Therapies Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Biorestorative Therapies Inc. revenue for the quarter ending March 31, 2026 was 23170, a 7.32% decrease year-over-year.
- Biorestorative Therapies Inc. revenue for the twelve months ending March 31, 2026 was 363270, a 6.47% decrease year-over-year.
- Biorestorative Therapies Inc. annual revenue for 2025 was 359700, a 10.30% decrease from 2024.
- Biorestorative Therapies Inc. annual revenue for 2024 was 401000, a 175.03% increase from 2023.
- Biorestorative Therapies Inc. annual revenue for 2023 was 145800, a 21.70% increase from 2022.
- Biorestorative Therapies Inc. annual revenue for 2022 was 119800.
Biorestorative Therapies Inc. (BRTX) — Frequently Asked Questions
Biorestorative Therapies Inc. (BRTX) is a publicly traded US company. It has a market capitalization of $3M. In fiscal 2025 it reported revenue of $359,700 and net income of -$14M. Explore BRTX's stock price, financial statements, earnings history, margins and key ratios below.
What is Biorestorative Therapies Inc.'s market cap?
Biorestorative Therapies Inc. (BRTX) has a market capitalization of $3M.
What is the BRTX stock price?
BRTX trades at $0.38 (-3.65% on the day).
How much revenue does Biorestorative Therapies Inc. make?
Biorestorative Therapies Inc. reported revenue of $359,700 in fiscal 2025.
Is BRTX profitable?
In fiscal 2025, Biorestorative Therapies Inc. reported net income of -$14M.